2 weeks Ago By ABMN Staff
Wallace Capital Management Inc. decreased its stake in shares of Haleon plc ( NYSE:HLN – Free Report ) by 1.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC.
The fund owned 80,136 shares of the company’s stock after selling 1,279 shares during the period. Wallace Capital Management Inc.’s holdings in Haleon were worth $662,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cultivar Capital Inc. acquired a new position in shares of Haleon in the 2nd quarter worth approximately $40,000.
Allspring Global Investments Holdings LLC bought a new stake in Haleon during the first quarter valued at $43,000. GAMMA Investing LLC raised its holdings in shares of Haleon by 151.3% during the first quarter.
GAMMA Investing LLC now owns 6,106 shares of the company’s stock worth $52,000 after purchasing an additional 3,676 shares during the period. Pinnacle Bancorp Inc. lifted its position in shares of Haleon by 29.
8% in the 1st quarter. Pinnacle Bancorp Inc. now owns 6,188 shares of the company’s stock worth $53,000 after buying an additional 1,421 shares during the last quarter.
Finally, Hexagon Capital Partners LLC grew its position in shares of Haleon by 66.6% during the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock valued at $55,000 after buying an additional 2,677 shares during the last quarter.
6.67% of the stock is owned by institutional investors. Wall Street Analyst Weigh In Several equities analysts have recently commented on HLN shares.
Berenberg Bank assumed coverage on Haleon in a report on Tuesday, August 6th. They set a “buy” rating for the company. The Goldman Sachs Group lowered shares of Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 6th.
Finally, Morgan Stanley lifted their price target on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a report on Friday, September 20th.
One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Haleon has an average rating of “Moderate Buy” and an average target price of $10.
95. Haleon Trading Up 0.8 % Shares of NYSE:HLN opened at $10.
67 on Monday. Haleon plc has a twelve month low of $7.70 and a twelve month high of $10.
80. The company has a current ratio of 0.84, a quick ratio of 0.
58 and a debt-to-equity ratio of 0.44. The firm has a market cap of $48.
72 billion, a P/E ratio of 35.57, a P/E/G ratio of 3.12 and a beta of 0.
26. The company has a 50 day moving average of $9.94 and a 200-day moving average of $8.
95. Haleon ( NYSE:HLN – Get Free Report ) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.
08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01).
Haleon had a net margin of 9.71% and a return on equity of 13.15%.
The firm had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion.
During the same quarter last year, the business posted $0.08 earnings per share. As a group, analysts anticipate that Haleon plc will post 0.
47 earnings per share for the current fiscal year. Haleon Cuts Dividend The firm also recently disclosed a semi-annual dividend, which was paid on Thursday, September 19th. Stockholders of record on Friday, August 16th were paid a $0.
0514 dividend. The ex-dividend date was Friday, August 16th. This represents a dividend yield of 1.
6%. Haleon’s dividend payout ratio is currently 33.33%.
About Haleon ( Free Report ) Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. Recommended Stories Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Haleon plc ( NYSE:HLN – Free Report ). Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter .
.
